Photons, Protons, SBRT, Brachytherapy—What Is Leading the Charge for the Management of Prostate Cancer? A Perspective From the GU Editorial Team

This publication has 43 references indexed in Scilit:

• A Pooled Analysis of Biochemical Failure in Intermediate-risk Prostate Cancer Following Definitive Stereotactic Body Radiotherapy (SBRT) or High-Dose-Rate Brachytherapy (HDR-B) Monotherapy
  American Journal of Clinical Oncology, 2018
• Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis
  European Urology, 2016
• SBRT and HDR brachytherapy produce lower PSA nadirs and different PSA decay patterns than conventionally fractionated IMRT in patients with low- or intermediate-risk prostate cancer
  Practical Radiation Oncology, 2016
• Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trial
  The Lancet Oncology, 2016
• Second malignancies after radiotherapy for prostate cancer: systematic review and meta-analysis
  BMJ, 2016
• Acute and Late Bowel Toxicity in Radiotherapy Patients with Inflammatory Bowel Disease: A Systematic Review
  Clinical Oncology, 2015
• Stereotactic Body Radiation Therapy for Prostate Cancer: Review of Experience of a Multicenter Phase I/II Dose-Escalation Study
  Frontiers in Oncology, 2014
• Will SBRT replace conventional radiotherapy in patients with low-intermediate risk prostate cancer? A review
  Critical Reviews in Oncology/Hematology, 2012
• Radiotherapy Treatment of Early-Stage Prostate Cancer with IMRT and Protons: A Treatment Planning Comparison
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
• Randomized Trial Comparing Iridium Implant Plus External-Beam Radiation Therapy With External-Beam Radiation Therapy Alone in Node-Negative Locally Advanced Cancer of the Prostate
  Journal of Clinical Oncology, 2005